Genetic and diabetic auto-antibody markers in Saudi children with type 1 diabetes

Human Immunology

Volumn 71, Issue 12, 2010, Pages 1238-1242

  Manan, Hakbany ^a   Angham, Al Mutair ^b   Sitelbanat, Awadalla ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

GAD; HLA; ICA 512; SSP; T1DM

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 65; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; ICA 512; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SAUDI ARABIA; SCHOOL CHILD; SCREENING;

ADOLESCENT; AGE OF ONSET; ALLELES; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE DECARBOXYLASE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; MALE; MEMBRANE GLYCOPROTEINS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; SAUDI ARABIA;

EID: 78149408711     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.09.008     Document Type: Article

References (43)

1. Eisenbarth G.S. Type 1 diabetes mellitus: A chronic autoimmune disease. N Engl J Med 1986, 314:1360-1368.
2. AL-Herbish A.S., EL-Mouzan M.I., Al-Salloum A.A., Al-Qurachi M.M., Al-Omar A.A. Prevalence of type 1 diabetes mellitus in Saudi children and adolescents. Saudi Med J 2008, 29(9):1285-1288.
3. Soltesz G.A. Worldwide childhood type 1 diabetes incidence - what can we learn from epidemiology?. Pediatric Diabetes 2007, 8(Suppl 6):6-14. CC Patterson bG Dahlquist c EURODIAB Study Group.
4. Green A. Epidemiology of type 1 (insulin-dependent) diabetes mellitus: Public health implications in the Middle East. Acta Paediatr Suppl 1999, 8:8-10.
5. Bell R.A., Mayer-Davise E.J., Beyer J.W., D'agodino R.B., Lawerence J.M., Linde B., et al. Diabetes in non-Hispanic white youth: Prevalence and clinical characterization. Diabetes Care 2009, 32(Suppl 2):s102-s111.
6. Karvonen M., Viik-Kajander M., Moltchanova E., Libman I., Laporte R., Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000, 23:1516-1526.
7. Todd J., Bell Jl, Mcdevitt H.O. HLA-DQ β gene contributes to susceptibility and resistance to insulin dependent diabetes mellitus. Nature 1987, 329:599-604.
8. Noble J.A., Valdes A.M., Cook M., Klitz W., Thomson G., Erlich H.A. The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996, 59:1134-1148.
9. Thomson G., Robinson W.P., Kuhner M.K., Joe S., MacDonald M.J., Gottschall J.L., et al. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet 1988, 43:799-816. [PubMed].
10. Valdes A.M., Thomson G. Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1. Diabetes Obes Metab 2009, 11(suppl 1):46-52. Type1 Diabetes Genetics Consortium.
11. Gorsuch A.N., Spencer K.M., Lister J., Mcnally J.M., Dean B.M., Bottazzo G.F., Cudworth A.G. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet 1981, 2:8260-8261. 1363-5.
12. Bottazzo G.F., Florin-Christensen A., Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974, Nov 30, 2:1279-1283.
13. Christie M.R., Vohra G., Champagne P., Daneman D., Delovitch T.L. Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. JEM 1990, 172:3789-3794. vol.
14. Payton M.A., Hawkes C.J., Christie M.R. Relationship of the 37,000 and 40,000 Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2. J Clin Invest 1995, 96:1506-1511. (ICA512).
15. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983, 222:1337-1339.
16. Borg H., Fernlund P., Sundkvist G. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus. Clin Chem 1997, 43:2358-2363.
17. Dittler J., Seidel D., Schenker M., Ziegler A.G. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes 1998, 47:592-597.
18. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
19. Lampasona V., Belloni C., Piquer S., Bonicchio S., Furlan R., Bonifacio E. Radiobinding assay for detecting auto antibodies to single epitopes. J Immunol Methods 2008, 31:127-134.
20. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Bland J.M., Altman D.G. Statistics notes. The odds ratio. BMJ 2000, 320:1468.
22. Stayoussef M., Benmansour J., Al-Jenaidi F.A., Nemr R., Ali M.E., Mahjoub T., Almawi W.Y. Influence of common and specific HLA-DRB1/DQB1 haplotypes on genetic susceptibilities of three distinct Arab populations to type 1 diabetes. Clin Vaccine Immunol 2009, 1:136-138.
23. Benedek G., Brautbar C., Vardi P., Sharon N., Weintrob N., Zung A., Israel S. Effect of polymorphism in insulin locus and HLA on type 1 diabetes in four ethnic groups in Israel. Tissue Antigens 2009, 73:33-38.
24. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., Concannon P., et al. Type1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: Analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57:1084-1092.
25. Katahira M., Ishiguro T., Segawa S., Kuzuya-Nagao K., Hara I., Nishisaki T. Reevaluation of human leukocyte antigen DR-DQ haplotype and genotype in type 1 diabetes in the Japanese population. Horm Res 2008, 69:284-289.
26. Hermann R., Bartsocas C.S., Soltész G., Vazeou A., Paschou P., Bozas E., et al. Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA Class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence. Diabetes/Metab Res Rev 2004, 20:322-329.
27. Latek R.R., Suri A., Petzold S.J., Nelson C.A., Kanagawa O., Unanue E.R., Fremont D.H. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 2000, 12:699-710.
28. Lee K.H., Wucherpfennig K.W., Wiley D.C., Lee K.H., Wucherpfennig D.C., Wiley K.W. 2001 Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2001, 2:501-507.
29. Haider M.Z., Shaltout A., Alsaeid K., Qabazard M., Dorman J. Prevalence of human leukocyte antigen DQA1 and DQB1 alleles in Kuwaiti Arab children with type 1 diabetes mellitus. Clin Genet 1999, 56:450-456.
30. Gaber S.A., Mazzola G., Berrino M., Canale L., Cornaglia M., Ghali I., et al. Human leukocyte antigen class II polymorphisms and genetic susceptibility of IDDM in Egyptian children. Diabetes Care 1994, 17:1341-1344.
31. Urcelay E., Santiago J.L., de la Calle H., Martínez A., Méndez J., Ibarra J.M., et al. Type 1 diabetes in the Spanish population: Additional factors to class II HLA-DR3 and -DR4. BMC Genomics 2005, 20:6. 56.
32. Paschou P., Bozas E., Dokopoulou M., Havarani B., Malamitsi-Puchner A., Ylli A., et al. HLA alleles and type 1 diabetes mellitus in low disease incidence populations of Southern Europe: A comparison of Greeks and Albanians. J Pediatr Endocrinol Metab 2004, 17:173-182.
33. Kelly M.A., Alvi N.S., Croft N.J., Mijovic C.H., Bottazzo G.F., Barnett A.H. Genetic and immunological characteristics of type I diabetes mellitus in an Indo-Aryan population. Diabetologia 2000, 43:450-456.
34. Altobelli E., Blasetti A., Petrocelli R., Tumini S., Azzarone R., Tiberti S., et al. HLA DR/DQ alleles and risk of type I diabetes in childhood: A population-based case-control study. Clin Exp Med 2005, 5:72-79.
35. Eller E., Vardi P., Mcfann K.K., Babu S.R., Yu L., Bugawan T.L., et al. Differential effects of DRB1*0301 and DQA1*0501-DQB1*0201 on the activation and progression of islet cell autoimmunity. Genes Immun 2007, 8:628-633.
36. Ilonen J., Kocova M., Lipponen K., Sukarova-Angelovska E., Jovanovska A., Knip M. HLA-DR-DQ haplotypes and type 1 diabetes in Macedonia. Hum Immunol 2009, 70:461-463.
37. Hermann R., Soltész G. Predictive genetic screening for type-1 diabetes in the Hungarian population. Orv Hetil 2004, 145:337-342.
38. Guja C., Guja L., Nutland S., Rance H., Sebastien M., Todd J.A., et al. Type 1 diabetes genetic susceptibility encoded by HLA DQB1 genes in Romania. J Cell Mol Med 2004, 8:249-256.
39. Parry C.S., Brook B.R. A new model defines the minimal set of polymorphism in HLA-DQ and DR that determines susceptibility and resistance to autoimmune diabetes. Biol Direct 2008, 3:42.
40. Park Y., Eisenbarth G.S. Genetic susceptibility factors of type 1 diabetes in Asians. Diabetes/Metab Res Rev 2001, 7:2-11.
41. Todd J.A. Etiology of type 1 diabetes. Immunity 2010, 32:457-467.
42. Price P., Cheong K.Y., Boodhoo A., Witt C.S., Mccann V., Christiansen F.T., et al. Can MHC class II genes mediate resistance to type 1 diabetes?. Immunol Cell Biol 2001, 79:602-606.
43. Orban T., Sosenko J.M., Cuthbertson D., Krischer J.P., Skyler J.S., Jackson R., et al. Pancreatic islet auto antibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 2009, 32:2269-2274. Diabetes Prevention Trial-Type 1 Study Group 2009.